Decreased reticuloendothelial system clearance and increased blood half-life and immune cell labeling for nano- and micron-sized superparamagnetic iron-oxide particles upon pre-treatment with Intralipid.
about
Combining perfluorocarbon and superparamagnetic iron-oxide cell labeling for improved and expanded applications of cellular MRI.Multi-modal contributions to detoxification of acute pharmacotoxicity by a triglyceride micro-emulsionA new approach to reduce toxicities and to improve bioavailabilities of platinum-containing anti-cancer nanodrugs.A Promising Emodin-Loaded Poly (Lactic-Co-Glycolic Acid)-d-α-Tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles for Liver Cancer Therapy.A New Method for Preparing Mesenchymal Stem Cells and Labeling with Ferumoxytol for Cell Tracking by MRINanoscintillator-mediated X-ray inducible photodynamic therapy for in vivo cancer treatment.Mn(II) mediated degradation of artemisinin based on Fe3O4@MnSiO3-FA nanospheres for cancer therapy in vivo.Reversal of Vascular Calcification and Aneurysms in a Rat Model Using Dual Targeted Therapy with EDTA- and PGG-Loaded NanoparticlesVincristine liposomes with smaller particle size have stronger diffusion ability in tumor and improve tumor accumulation of vincristine significantly.A New Approach to Deliver Anti-cancer Nanodrugs with Reduced Off-target Toxicities and Improved Efficiency by Temporarily Blunting the Reticuloendothelial System with Intralipid.Priming the body to receive the therapeutic agent to redefine treatment benefit/risk profile.The Use of Magnetic Resonance Imaging for Non-Invasive Assessment of Venofer® Biodistribution in Rats.Lipoamino Acid Coated Superparamagnetic Iron Oxide Nanoparticles Concentration and Time Dependently Enhanced Growth of Human Hepatocarcinoma Cell Line (Hep-G2)
P2860
Q33969361-71096600-A820-4C8B-9F3D-6D59C48B6322Q34944369-6C9BF01B-2F01-4951-82ED-A9F232A0748FQ35679127-2EAC698A-7F85-4503-9AFE-5EE051FF72D5Q35762916-3CC55802-8D84-4C84-9D1F-3E602FA526C5Q36911124-9154D5E4-CF5F-44DF-8CA4-402244BB3673Q37584064-45EBAEE8-88DB-47FD-A112-101FE1D62CB6Q38857018-2117E7BC-4A1B-4ED5-967C-BD74581B5E80Q41200985-824D9B73-277D-49A9-A13F-C85F880DAD88Q47156854-7A9F401C-779B-4B89-A2B9-DC3D031036EAQ47162722-6FD4FDA7-ED9A-4194-9D10-CDAE310421E3Q55020915-82D69193-A75E-4F4A-BCD3-B3C8A4755259Q55400937-A3F35D8D-82CD-4830-ADA3-739C30EC7F4FQ59113478-A99003C8-B25E-4B0C-B0C7-3A44EA1AB88E
P2860
Decreased reticuloendothelial system clearance and increased blood half-life and immune cell labeling for nano- and micron-sized superparamagnetic iron-oxide particles upon pre-treatment with Intralipid.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Decreased reticuloendothelial ...... pre-treatment with Intralipid.
@ast
Decreased reticuloendothelial ...... pre-treatment with Intralipid.
@en
type
label
Decreased reticuloendothelial ...... pre-treatment with Intralipid.
@ast
Decreased reticuloendothelial ...... pre-treatment with Intralipid.
@en
prefLabel
Decreased reticuloendothelial ...... pre-treatment with Intralipid.
@ast
Decreased reticuloendothelial ...... pre-treatment with Intralipid.
@en
P2093
P2860
P50
P1476
Decreased reticuloendothelial ...... pre-treatment with Intralipid.
@en
P2093
Brent Barbe
Daniel J Bain
Devin E Prior
Lesley M Foley
T Kevin Hitchens
Wendy F Li
P2860
P304
P356
10.1016/J.BBAGEN.2013.01.021
P407
P577
2013-02-08T00:00:00Z